ANIX Anixa Biosciences, Inc.
Anixa Biosciences, Inc. (ANIX) is expected to report earnings on September 9, 2026, after the market close. The consensus earnings estimate is a loss of $0.08 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +32.5% since its last earnings release on June 10, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Anixa Biosciences, Inc.
Anixa Biosciences, Inc. operates as a bio-technology company. It develops diagnostics and therapeutics to detect cancer. Anixa Biosciences Inc., formerly known as ITUS Corporation, is based in San Jose, United States.
Sector
Healthcare
Industry
Biotechnology